These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 29072481)

  • 21. Neurobehavioral symptom validity in U.S. Department of Veterans Affairs (VA) mild traumatic brain injury evaluations.
    Ashendorf L
    J Clin Exp Neuropsychol; 2019 May; 41(4):432-441. PubMed ID: 30712457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a Response Bias Scale (RBS) for the MMPI-2.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Assessment; 2007 Jun; 14(2):196-208. PubMed ID: 17504891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can brief measures effectively screen for pain and somatic malingering? Examination of the Modified Somatic Perception Questionnaire and Pain Disability Index.
    Crighton AH; Wygant DB; Applegate KC; Umlauf RL; Granacher RP
    Spine J; 2014 Sep; 14(9):2042-50. PubMed ID: 24768750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
    Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examination of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) validity and substantive scales in patients with electrical injury.
    Soble JR; Resch ZJ; Schulze ET; Paxton JL; Cation B; Friedhoff C; Costin C; Fink JW; Lee RC; Pliskin NH
    Clin Neuropsychol; 2019 Nov; 33(8):1501-1515. PubMed ID: 31106672
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility of the MMPI-2-RF neurological complaints and cognitive complaints scales to over-reporting in simulated head injury.
    Bolinger E; Reese C; Suhr J; Larrabee GJ
    Arch Clin Neuropsychol; 2014 Feb; 29(1):7-15. PubMed ID: 24191968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) over-reporting scales in a military neuropsychology clinic.
    Ingram PB; Golden BL; Armistead-Jehle PJ
    J Clin Exp Neuropsychol; 2020 Apr; 42(3):263-273. PubMed ID: 31900041
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparing the Ability of MMPI-2 and MMPI-2-RF Validity Scales to Detect Feigning: A Meta-Analysis.
    Aparcero M; Picard EH; Nijdam-Jones A; Rosenfeld B
    Assessment; 2023 Apr; 30(3):744-760. PubMed ID: 34991350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further validation of the MMPI-2 and MMPI-2-RF Response Bias Scale: findings from disability and criminal forensic settings.
    Wygant DB; Sellbom M; Gervais RO; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Psychol Assess; 2010 Dec; 22(4):745-56. PubMed ID: 20919770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An examination of the MMPI-3 validity scales in detecting overreporting of psychological problems.
    Reeves CK; Brown TA; Sellbom M
    Psychol Assess; 2022 Jun; 34(6):517-527. PubMed ID: 35201824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validating the usefulness of the NSI validity-10 with the MMPI-2-RF.
    Gradwohl BD; Mangum RW; Tolle KA; Pangilinan PH; Bieliauskas LA; Spencer RJ
    Int J Neurosci; 2020 Sep; 130(9):926-932. PubMed ID: 31928283
    [No Abstract]   [Full Text] [Related]  

  • 33. MMPI-2-RF Profiles of Treatment-Seeking Veterans in a VA Pain Clinic and Associations with Markers of Physical Performance.
    Wolf EJ; Higgins DM; Zhao X; Hawn SE; Sanborn V; Todd CA; Fein-Schaffer D; Houranieh A; Miller MW
    J Clin Psychol Med Settings; 2024 Mar; 31(1):58-76. PubMed ID: 37418093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Minnesota Multiphasic Personality Inventory-2-RF in Treatment-Seeking Veterans with History of Mild Traumatic Brain Injury.
    Jurick SM; Crocker LD; Keller AV; Hoffman SN; Bomyea J; Jacobson MW; Jak AJ
    Arch Clin Neuropsychol; 2018 May; 34(3):366-380. PubMed ID: 29850866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychometric perspectives on detection of malingering of pain: use of the Minnesota Multiphasic Personality Inventory-2.
    Arbisi PA; Butcher JN
    Clin J Pain; 2004; 20(6):383-91. PubMed ID: 15502681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability and validity of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) in evaluations of chronic low back pain patients.
    Tarescavage AM; Scheman J; Ben-Porath YS
    Psychol Assess; 2015 Jun; 27(2):433-446. PubMed ID: 25436662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting negative response bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2.
    Dionysus KE; Denney RL; Halfaker DA
    Arch Clin Neuropsychol; 2011 Mar; 26(2):81-8. PubMed ID: 21148668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inconsistent responding on the MMPI-2-RF and uncooperative attitude: Evidence from cognitive performance validity measures.
    Gervais RO; Tarescavage AM; Greiffenstein MF; Wygant DB; Deslauriers C; Arends P
    Psychol Assess; 2018 Mar; 30(3):410-415. PubMed ID: 28627922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.